Page 952 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 952

53                          Clinical Pharmacology of
                         C  H   A  P   T  E  R








                                                     the Antihelminthic Drugs




                                                     Philip J. Rosenthal, MD











                   C ASE  STUD Y

                   A 29-year-old Peruvian man presents with the incidental   immigrated to the USA 10 years ago from a rural area of
                   finding of a 10 × 8 × 8-cm liver cyst on an abdominal com-  Peru where his family trades in sheepskins. His father and
                   puted tomography (CT) scan. The patient had noted 2 days   sister  have undergone resection of abdominal masses,
                   of abdominal pain and fever, and his clinical evaluation and   but  details of  their  diagnoses are unavailable.  What is
                   CT scan were consistent with appendicitis. His clinical find-  your differential diagnosis? What are your diagnostic and
                   ings resolved after laparoscopic appendectomy. The patient   therapeutic plans?




                 ■   CHEMOTHERAPY OF                                 ALBENDAZOLE
                 HELMINTHIC INFECTIONS                               Albendazole, a broad-spectrum oral antihelminthic, is the drug of

                                                                     choice and is approved in the USA for treatment of hydatid disease
                 Helminths (worms) are multicellular organisms that infect very   and cysticercosis. It is also used in the treatment of pinworm and
                 large numbers of humans and cause a broad range of diseases.   hookworm infections, ascariasis, trichuriasis, and strongyloidiasis.
                 More than 1 billion people are infected with intestinal nematodes,
                 and many millions are infected with filarial nematodes, flukes,   Basic Pharmacology
                 and tapeworms in other organs. Many drugs, directed against
                 a number of different targets, are available to treat helminthic   Albendazole is a benzimidazole carbamate. After oral adminis-
                 infections. In many cases, especially in the developing world, the   tration, it is erratically absorbed (increased with a fatty meal)
                 goal is control of infection, with elimination of most parasites,   and then rapidly undergoes first-pass metabolism in the liver to
                 alleviating disease symptoms, and decreasing the transmission of   the  active  metabolite  albendazole  sulfoxide.  It  reaches  variable
                 infection. In other cases, complete elimination of parasites is the   maximum plasma concentrations about 3 hours after a 400-mg
                 goal of therapy, although this goal can be challenging with certain   oral dose, and its plasma half-life is 8–12 hours. The sulfoxide is
                 helminthic infections, because of both limited efficacy of drugs   mostly protein-bound, distributes well to tissues, and enters bile,
                 and frequent reinfection after therapy in endemic areas.  cerebrospinal fluid, and hydatid cysts. Albendazole metabolites are
                   Table 53–1 lists the major helminthic infections and provides   excreted in the urine.
                 a guide to the drug of choice and alternative drugs for each infec-  Benzimidazoles are thought to act against nematodes by inhibit-
                 tion. In the text that follows, these drugs are arranged alphabeti-  ing microtubule synthesis. Albendazole also has larvicidal effects in
                 cally. In general, parasites should be identified before treatment   hydatid disease, cysticercosis, ascariasis, and hookworm infection
                 is started.                                         and ovicidal effects in ascariasis, ancylostomiasis, and trichuriasis.





                 938
   947   948   949   950   951   952   953   954   955   956   957